Clinical Laserthermia Systems announces that the date for conversion of interim shares is estimated to February 21, 2024
Lund, Sweden - Today, February 14, 2024, Clinical Laserthermia Systems AB ("CLS" or the "Company") announces that 189,182,414 new B-shares have been registered with the Swedish Companies Registration Office, as a result of the exercise of warrants of series TO 6 B ("TO 6 B").Conversion of interim shares to ordinary B-shares takes place around February 21, 2024, and are expected to be available on each subscriber's account around February 23, 2024. The total number of shares in the Company as a result of the warrant exercise of TO 6 B and the directed new share issue to underwriters in